| 000 | 00000nam 2200000zi 4500 |
| 001 | 9.898655 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20240724144713 |
|---|
| 006 | m o d f |
|---|
| 007 | cr ||||||||||| |
|---|
| 008 | 210413t20212019onc ob f00| 0 eng d |
|---|
| 020 | |a9780660384337 |
|---|
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aHP40-286/2021E-PDF |
|---|
| 245 | 00|aUse of measles-mumps-rubella (MMR) vaccine for the management of mumps outbreaks in Canada. |
|---|
| 250 | |a[July 2021 edition]. |
|---|
| 264 | 1|a[Ottawa] : |bPublic Health Agency of Canada = Agence de la santé publique du Canada,|c2021. |
|---|
| 264 | 4|c©2019 |
|---|
| 300 | |a1 online resource (50 pages) |
|---|
| 336 | |atext|btxt|2rdacontent |
|---|
| 337 | |acomputer|bc|2rdamedia |
|---|
| 338 | |aonline resource|bcr|2rdacarrier |
|---|
| 500 | |aIssued also in French under title: Utilisation du vaccin contre la rougeole, la rubéole et les oreillons (RRO) pour la prise en charge des éclosions d’oreillons au Canada. |
|---|
| 500 | |aAt head of title: An Advisory Committee Statement (ACS), National Advisory Committee on Immunization (NACI). |
|---|
| 500 | |a"Publication date: July 2021." |
|---|
| 504 | |aIncludes bibliographical references (pages 33-39). |
|---|
| 650 | 0|aMumps|xVaccination|zCanada. |
|---|
| 710 | 2 |aPublic Health Agency of Canada, |eissuing body. |
|---|
| 710 | 1 |aCanada. |bNational Advisory Committee on Immunization, |eissuing body. |
|---|
| 775 | 08|tUtilisation du vaccin contre la rougeole, la rubéole et les oreillons (RRO) pour la prise en charge des éclosions d’oreillons au Canada.|w(CaOODSP)9.898656 |
|---|
| 794 | |tUse of measles-mumps-rubella (MMR) vaccine for the management of mumps outbreaks in Canada.|b[Revised 2024 edition]|w(CaOODSP)9.937672 |
|---|
| 856 | 40|qPDF|s693 KB|uhttps://publications.gc.ca/collections/collection_2021/aspc-phac/HP40-286-2021-eng.pdf |
|---|
| 986 | |a210041 |
|---|